FI980488A0 - New diagnostic methods - Google Patents

New diagnostic methods

Info

Publication number
FI980488A0
FI980488A0 FI980488A FI980488A FI980488A0 FI 980488 A0 FI980488 A0 FI 980488A0 FI 980488 A FI980488 A FI 980488A FI 980488 A FI980488 A FI 980488A FI 980488 A0 FI980488 A0 FI 980488A0
Authority
FI
Finland
Prior art keywords
diagnostic methods
new diagnostic
new
methods
diagnostic
Prior art date
Application number
FI980488A
Other languages
Finnish (fi)
Other versions
FI980488A (en
Inventor
Maciej Krzysztof Kwiatkowski
Jonas Kurt Hugosson
Hans Lilja
Timo Loevgren
Kim Pettersson
Timo Piironen
Franz Helmut Richard Recker
Original Assignee
Arctic Partners Oy Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arctic Partners Oy Ab filed Critical Arctic Partners Oy Ab
Priority to FI980488A priority Critical patent/FI980488A/en
Publication of FI980488A0 publication Critical patent/FI980488A0/en
Priority to EP99902563A priority patent/EP1068534A1/en
Priority to PCT/FI1999/000073 priority patent/WO1999045398A1/en
Priority to JP2000534884A priority patent/JP2002506210A/en
Publication of FI980488A publication Critical patent/FI980488A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96455—Kallikrein (3.4.21.34; 3.4.21.35)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI980488A 1998-03-04 1998-03-04 New diagnostic method FI980488A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FI980488A FI980488A (en) 1998-03-04 1998-03-04 New diagnostic method
EP99902563A EP1068534A1 (en) 1998-03-04 1999-02-03 Method for differentiation of prostate cancer
PCT/FI1999/000073 WO1999045398A1 (en) 1998-03-04 1999-02-03 Method for differentiation of prostate cancer
JP2000534884A JP2002506210A (en) 1998-03-04 1999-02-03 How to identify prostate cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI980488A FI980488A (en) 1998-03-04 1998-03-04 New diagnostic method

Publications (2)

Publication Number Publication Date
FI980488A0 true FI980488A0 (en) 1998-03-04
FI980488A FI980488A (en) 1999-09-05

Family

ID=8551117

Family Applications (1)

Application Number Title Priority Date Filing Date
FI980488A FI980488A (en) 1998-03-04 1998-03-04 New diagnostic method

Country Status (4)

Country Link
EP (1) EP1068534A1 (en)
JP (1) JP2002506210A (en)
FI (1) FI980488A (en)
WO (1) WO1999045398A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI990382A0 (en) * 1999-02-23 1999-02-23 Arctic Partners Oy Ab New diagnostic method
EP1269194B1 (en) * 2000-03-20 2007-03-07 Eastern Virginia Medical School Prostate cancer markers
US20050037447A1 (en) * 2003-07-08 2005-02-17 Yong-Chuan Wong Protein markers for human benign prostatic hyperplasia (BPH)
US8663600B2 (en) * 2005-02-17 2014-03-04 Diaprost Ab Diagnosis of prostate cancer
EP2913405B1 (en) 2010-07-27 2016-11-09 Genomic Health, Inc. Method for using gene expression to determine prognosis of prostate cancer
DK3011059T3 (en) 2013-06-20 2019-05-13 Immunexpress Pty Ltd IDENTIFICATION biomarker
WO2015117204A1 (en) * 2014-02-06 2015-08-13 Immunexpress Pty Ltd Biomarker signature method, and apparatus and kits therefor
SG10201808585TA (en) 2014-03-28 2018-11-29 Opko Diagnostics Llc Compositions and methods related to diagnosis of prostate cancer
ES2867798T3 (en) 2015-03-27 2021-10-20 Opko Diagnostics Llc Prostate Antigen Standards and Uses of These
CN116242787A (en) * 2023-03-07 2023-06-09 厦门大学 High specificity spectrum detection method for prostate cancer and cancer judgment device

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614372A (en) * 1995-02-24 1997-03-25 Lilja; Hans Early detection of prostate cancer (CAP) by employing prostate specific antigen (PSA) and human glandular kallikrein (hGK-1)
GB2302874B (en) * 1995-06-29 1999-11-10 Orion Yhtymae Oy Novel proteins

Also Published As

Publication number Publication date
WO1999045398A1 (en) 1999-09-10
FI980488A (en) 1999-09-05
JP2002506210A (en) 2002-02-26
EP1068534A1 (en) 2001-01-17

Similar Documents

Publication Publication Date Title
NO20005503L (en) New use
NO991944L (en) New connection
DE69931795D1 (en) MICROSENSOR
FI972736A0 (en) Foerbaettrad method Foer cellbyte
NO20001830D0 (en) New combination
DE69917184D1 (en) recorder
NO20003996D0 (en) New connection
NO993298L (en) New procedure
DE69929547D1 (en) recorder
DE69933629D1 (en) RECORDER
FI980488A0 (en) New diagnostic methods
NO995796L (en) New procedure
DE69919457D1 (en) probe
ID28840A (en) TESTING
DE69902955D1 (en) Microtome
FI990382A0 (en) New diagnostic method
FI981431A0 (en) Measuring method
FI981185A (en) New diagnostic method
FI982722A (en) Diagnostic method
FI980950A (en) New diagnostic method
FI981207A0 (en) demodulation method
FI980165A0 (en) Diagnostic foherfarande
FR2778285B1 (en) INTEGRATED ALTERNATOR-STARTER
FIU980597U0 (en) inspection Well
SE9802918D0 (en) Dianostic test